These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12393509)

  • 1. Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines.
    Ge Y; Jensen TL; Matherly LH; Taub JW
    Blood; 2003 Feb; 101(4):1551-7. PubMed ID: 12393509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of cell-specific expression of the human cystathionine beta -synthase gene by differential binding of Sp1/Sp3 to the -1b promoter.
    Ge Y; Matherly LH; Taub JW
    J Biol Chem; 2001 Nov; 276(47):43570-9. PubMed ID: 11562358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.
    Ge Y; Konrad MA; Matherly LH; Taub JW
    Biochem J; 2001 Jul; 357(Pt 1):97-105. PubMed ID: 11415440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines.
    Ge Y; Jensen TL; Stout ML; Flatley RM; Grohar PJ; Ravindranath Y; Matherly LH; Taub JW
    Cancer Res; 2004 Jan; 64(2):728-35. PubMed ID: 14744791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic regulation of human cystathionine-beta-synthase-1b promoter by transcription factors NF-YA isoforms and Sp1.
    Ge Y; Jensen TL; Matherly LH; Taub JW
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):73-80. PubMed ID: 12427542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
    Ge Y; Dombkowski AA; LaFiura KM; Tatman D; Yedidi RS; Stout ML; Buck SA; Massey G; Becton DL; Weinstein HJ; Ravindranath Y; Matherly LH; Taub JW
    Blood; 2006 Feb; 107(4):1570-81. PubMed ID: 16249385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dominant role of Sp1 in regulating the cystathionine beta-synthase -1a and -1b promoters facilitates potential tissue-specific regulation by Kruppel-like factors.
    Maclean KN; Kraus E; Kraus JP
    J Biol Chem; 2004 Mar; 279(10):8558-66. PubMed ID: 14670973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
    Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
    Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
    Taub JW; Huang X; Matherly LH; Stout ML; Buck SA; Massey GV; Becton DL; Chang MN; Weinstein HJ; Ravindranath Y
    Blood; 1999 Aug; 94(4):1393-400. PubMed ID: 10438727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
    Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
    PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity.
    Ge Y; Jensen TL; Matherly LH; Taub JW
    J Biol Chem; 2003 Dec; 278(50):49901-10. PubMed ID: 14514691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions.
    Yamada K; Tanaka T; Miyamoto K; Noguchi T
    J Biol Chem; 2000 Jun; 275(24):18129-37. PubMed ID: 10748033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.
    Jean D; Guillaume N; Frade R
    Biochem J; 2002 Jan; 361(Pt 1):173-84. PubMed ID: 11742542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of specific proteins (Sp1/Sp3) and nuclear factor Y in basal transcription of the distal promoter of the rat pyruvate carboxylase gene in beta-cells.
    Sunyakumthorn P; Boonsaen T; Boonsaeng V; Wallace JC; Jitrapakdee S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):188-96. PubMed ID: 15721292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
    Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
    Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
    Rothem L; Aronheim A; Assaraf YG
    J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO.
    Xu Y; Carr LG
    Gene; 2001 Aug; 274(1-2):119-28. PubMed ID: 11675004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.